Canada Canada was an outlier on mixing COVID-19 vaccines, but more countries now following suit
COVID-19 vaccine trials for children are ongoing. How do they differ from adults?
In Canada, only Pfizer’s COVID-19 vaccine has been authorized for use in children aged 12 years and up, while trials are under way for younger age groups.In Canada, so far only Pfizer-BioNTech’s COVID-19 vaccine has been authorized for use in children aged 12 years and above. Moderna submitted its application for approval to Health Canada in June.
Canada became an outlierin the global fight against COVID-19 by allowing residents to mix various coronavirus vaccines.
But while the approach, in place for more than a month, has been controversial —, and preventing people from — it's now increasingly being explored by other countries.
"It's not unusual to mix and match," said Angela Rasmussen, a virologist with the Vaccine and Infectious Disease Organization in Saskatoon.
Why mandatory COVID-19 vaccines for health-care workers could help Canada fight a 4th wave
The debate over mandatory COVID-19 vaccines for health-care workers is growing louder in Canada as more countries move forward with the controversial approach to safeguard health-care settings and fight the spread of more contagious variants.Requiring vaccinations as a condition of employment in hospitals, long-term care homes and other sectors involving hands-on work with patients is not new in Canada — and experts feel it should be no different when it comes to this pandemic.
"I think that it does create a more flexible situation which is really good overall, because we don't need to just think about vaccinating everybody in Canada — we need to think about vaccinating everybody in the world."
A growing number of countries are considering swapping in different COVID-19 vaccines into their programs as second doses or boosters, in light of supply delays and safety concerns tied to certain other shots.
Bahrain, Bhutan, Indonesia, Italy, Thailand, the United Arab Emirates, Uruguay and Vietnam are among those now exploring or actively pursuing mixed-dosing strategies.
It's a move increasingly backed by new research, though it's rooted in decades of vaccine science, according to Rasmussen and other vaccine experts.
The European Union has provided only a small part of the vaccines promised to the poor countries
© Jon Nazca Vaccines and poor countries, Europe does not hold its promise according to an internal document, consulted by Reuters, the The European Union has not, for the moment, its commitment to contribute to the vaccination of the most vulnerable people in the world.
"Combining vaccines is nothing new," she said. "There's no reason to expect that it wouldn't be safe."
"It is already accepted around the world for other vaccines," she said. "Do you ask what flu vaccine you get every year? They're made by different manufacturers."
For some countries, including Italy and Vietnam, the goal is to provide people who were first immunized with the AstraZeneca-Oxford vaccine with a second dose of an mRNA product, such as Pfizer-BioNTech.
Video: COVID-19: What we know about mixing vaccines (cbc.ca)
That's similar to Canada's guiding recommendations from the National Advisory Committee on Immunization (NACI), which allow swapping in different vaccines for different doses in certain situations.
The advisory body recommends that either AstraZeneca or mRNA-based vaccines — Moderna's is the other approved in Canada — can be offered as a second dose for people who had a first shot of AstraZeneca.
As Canada hits COVID-19 vaccine milestone, reducing barriers to access key: experts
Canadian Prime Minister Justin Trudeau announced on Tuesday that Prince Edward Island (P.E.I.) has become the third province to sign on to the government national child-care program, which would create $10-dollar-a-day child care for children under six year old.
But the group notes that mRNA options are preferred as a second dose, thanks to emerging safety evidence and the possibility of a better immune response.
Mixing doses of the Pfizer and AstraZeneca vaccines actually generate a stronger immune response than having two rounds of AstraZeneca,.
More recently,, a similar study of nearly 500 medical workers in South Korea also showed that approach — AstraZeneca first, followed by a Pfizer booster — increased neutralizing antibody levels by six times, compared to two doses of AstraZeneca.
Canada's NACI also calls for the same mRNA vaccines to be used for a second dose if possible, but says another mRNA shot "can be considered interchangeable" if the first type is unavailable.
When it comes to rising global uptake of a mixed vaccine approach, there's a "certain degree of pragmatism," said Dr. Alexander Wong, an infectious diseases specialist with the University of Saskatchewan.
Not every country has "superb access" to mRNA shots, which are "really kind of the bottom line," he said.
Some countries, like Thailand and the United Arab Emirates, are allowing the Pfizer shot to be used a booster for those first vaccinated with one of the leading Chinese vaccines, made by Sinovac and Sinopharm — though there's no research on whether that would hike people's level of protection.
"We just need some more hard and fast clinical data," he said.
Wong also says there's still controversy around the world about mixing different brands and technologies.
While some countries are adopting a mixed dosing schedule, others are outright blocking people from entry if they mixed certain vaccines — and it's aand overseas tourist attractions.
Coronavirus live updates: Quebec is phasing out business site vaccination clinics .
Updated throughout the day on Wednesday, Aug. 4. Questions/comments: email@example.com Top updates: Quebec will announce new COVID-19 measures in the coming days: Legault Quebec provides update on vaccine campaign, will be phasing out some clinics Montrealers are waiting too long to get COVID-19 tests, public health says WHO calls for moratorium on booster shots Capitale-Nationale reaches 75% vaccination rate Quebec reports 184 new cases, no deaths 4 p.m.